143 related articles for article (PubMed ID: 26623479)
1. Intracellular Target-Specific Accretion of Cell Penetrating Peptides and Bioportides: Ultrastructural and Biological Correlates.
Jones S; Uusna J; Langel Ü; Howl J
Bioconjug Chem; 2016 Jan; 27(1):121-9. PubMed ID: 26623479
[TBL] [Abstract][Full Text] [Related]
2. Insights into the molecular mechanisms of action of bioportides: a strategy to target protein-protein interactions.
Howl J; Jones S
Expert Rev Mol Med; 2015 Jan; 17():e1. PubMed ID: 26258595
[TBL] [Abstract][Full Text] [Related]
3. Bioportides: bioactive cell-penetrating peptides that modulate cellular dynamics.
Lukanowska M; Howl J; Jones S
Biotechnol J; 2013 Aug; 8(8):918-30. PubMed ID: 23843291
[TBL] [Abstract][Full Text] [Related]
4. Intracellular translocation and differential accumulation of cell-penetrating peptides in bovine spermatozoa: evaluation of efficient delivery vectors that do not compromise human sperm motility.
Jones S; Lukanowska M; Suhorutsenko J; Oxenham S; Barratt C; Publicover S; Copolovici DM; Langel Ü; Howl J
Hum Reprod; 2013 Jul; 28(7):1874-89. PubMed ID: 23585561
[TBL] [Abstract][Full Text] [Related]
5. Protein Mimicry and the Design of Bioactive Cell-Penetrating Peptides.
Howl J; Jones S
Methods Mol Biol; 2015; 1324():177-90. PubMed ID: 26202270
[TBL] [Abstract][Full Text] [Related]
6. Bioportide: an emergent concept of bioactive cell-penetrating peptides.
Howl J; Matou-Nasri S; West DC; Farquhar M; Slaninová J; Ostenson CG; Zorko M; Ostlund P; Kumar S; Langel U; McKeating J; Jones S
Cell Mol Life Sci; 2012 Sep; 69(17):2951-66. PubMed ID: 22527714
[TBL] [Abstract][Full Text] [Related]
7. Protein Mimicry and the Design of Bioactive Cell-Penetrating Peptides: The Genesis of STOPSPERM Bioportides.
Howl J; Silva JV; Fardilha M; Jones S
Methods Mol Biol; 2022; 2383():293-306. PubMed ID: 34766298
[TBL] [Abstract][Full Text] [Related]
8. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
9. The planarian Schmidtea mediterranea as a model system for the discovery and characterization of cell-penetrating peptides and bioportides.
Jones S; Osman S; Howl J
Chem Biol Drug Des; 2019 Jun; 93(6):1036-1049. PubMed ID: 30790457
[TBL] [Abstract][Full Text] [Related]
10. Cell-penetrating peptide exploited syndecans.
Letoha T; Keller-Pintér A; Kusz E; Kolozsi C; Bozsó Z; Tóth G; Vizler C; Oláh Z; Szilák L
Biochim Biophys Acta; 2010 Dec; 1798(12):2258-65. PubMed ID: 20138023
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
[TBL] [Abstract][Full Text] [Related]
12. EJP18 peptide derived from the juxtamembrane domain of epidermal growth factor receptor represents a novel membrane-active cell-penetrating peptide.
Eissa NG; Sayers EJ; Birch D; Patel SG; Tsai YH; Nielsen HM; Jones AT
Biochem J; 2020 Jan; 477(1):45-60. PubMed ID: 31820794
[TBL] [Abstract][Full Text] [Related]
13. Cell penetrating peptide-mediated transport enables the regulated secretion of accumulated cargoes from mast cells.
Howl J; Jones S
J Control Release; 2015 Mar; 202():108-17. PubMed ID: 25660072
[TBL] [Abstract][Full Text] [Related]
14. Novel cell-penetrating peptide targeting mitochondria.
Cerrato CP; Pirisinu M; Vlachos EN; Langel Ü
FASEB J; 2015 Nov; 29(11):4589-99. PubMed ID: 26195590
[TBL] [Abstract][Full Text] [Related]
15. Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging.
Wang W; Abbad S; Zhang Z; Wang S; Zhou J; Lv H
Curr Cancer Drug Targets; 2015; 15(4):337-51. PubMed ID: 25669720
[TBL] [Abstract][Full Text] [Related]
16. Toxin bioportides: exploring toxin biological activity and multifunctionality.
Kerkis I; de Brandão Prieto da Silva AR; Pompeia C; Tytgat J; de Sá Junior PL
Cell Mol Life Sci; 2017 Feb; 74(4):647-661. PubMed ID: 27554773
[TBL] [Abstract][Full Text] [Related]
17. A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy".
Shi NQ; Qi XR; Xiang B; Zhang Y
J Control Release; 2014 Nov; 194():53-70. PubMed ID: 25151981
[TBL] [Abstract][Full Text] [Related]
18. Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses.
Zappavigna S; Misso G; Falanga A; Perillo E; Novellino E; Galdiero M; Grieco P; Caraglia M; Galdiero S
Curr Pharm Biotechnol; 2016; 17(8):700-22. PubMed ID: 27087493
[TBL] [Abstract][Full Text] [Related]
19. Cell-penetrating peptide-functionalized quantum dots for intracellular delivery.
Liu BR; Huang YW; Chiang HJ; Lee HJ
J Nanosci Nanotechnol; 2010 Dec; 10(12):7897-905. PubMed ID: 21121277
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier.
Young Kim H; Young Yum S; Jang G; Ahn DR
Sci Rep; 2015 Jun; 5():11719. PubMed ID: 26114640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
